Open AccessResults of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma
Author(s) -
Richard F. Riedel,
Victoria S. Chua,
Ania Moradkhani,
Natalie Krkyan,
Amir Ahari,
Atsushi Osada,
Sant P. Chawla
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac155
Subject(s) - medicine , epirubicin , neutropenia , anthracycline , gastroenterology , leukopenia , adverse effect , cohort , clinical endpoint , angiosarcoma , surgery , oncology , chemotherapy , cancer , randomized controlled trial , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom